15
Participants
Start Date
May 1, 2025
Primary Completion Date
November 1, 2025
Study Completion Date
January 1, 2026
Lead Sponsor
Collaborators (1)
Syneos Health
OTHER
CHU de Quebec-Universite Laval
MindImmune Therapeutics, Inc.
INDUSTRY